Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FB 825

Next Previous
X
Search
Drug Profile

FB 825

Alternative Names: Anti-CemX; Anti-CEmX monoclonal antibody - Fountain Biopharma; Anti-CEmX monoclonal antibody - Oneness Biotech; FB-825; FB825-15D11; h4B12; LP0201

Latest Information Update: 13 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Academia Sinica
  • Developer Fountain BioPharma; Oneness Biotech
  • Class Anti-inflammatories; Antiallergics; Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Job syndrome
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Allergic asthma; Atopic dermatitis; Job syndrome
  • No development reported Allergic rhinitis

Most Recent Events

  • 30 Jan 2024 Oneness Biotech files an IND application with the US FDA in the US for phase II trial in Atopic dermatitis
  • 30 Jan 2024 Oneness biotech plans a phase II trial for Atopic dermatitis in the US (SC)
  • 03 May 2023 Phase-I clinical trials in Atopic dermatitis (In volunteers) in USA (SC) (NCT05952986)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top